4526 — Riken Vitamin Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥79bn
- ¥67bn
- ¥96bn
- 73
- 72
- 88
- 92
Annual cashflow statement for Riken Vitamin Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7 | 20,313 | 7,857 | 11,909 | 12,706 |
| Depreciation | |||||
| Non-Cash Items | 1,260 | -13,674 | -492 | -1,976 | -4,734 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2,416 | -3,551 | -3,248 | -2,812 | -3,283 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 7,624 | 6,824 | 7,835 | 10,451 | 7,893 |
| Capital Expenditures | -3,770 | -3,360 | -2,127 | -2,982 | -4,812 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,482 | -301 | 93 | 2,428 | 5,165 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,288 | -3,661 | -2,034 | -554 | 353 |
| Financing Cash Flow Items | -27 | -543 | -20 | -24 | -11 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -180 | -7,565 | -4,578 | -7,084 | -9,965 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5,051 | -3,591 | 1,592 | 3,485 | -1,306 |